Trial intelligence / Profile preview

CIRCE: Contrast-enhanced Ultrasound and Splenic Elastography for Portal Hypertension in Cirrhosis

NCT07365709Not yet recruiting

Sponsor
Policlinico Gemelli
Start
Feb 2026
Primary completion
Jul 2026
Modality
Small Molecules
01

Overview

Single-arm trial of sulfur hexafluoride in Portal Hypertension (PH) and Liver cirrhosis (LC), sponsored by Policlinico Gemelli. Planned start Feb 2026; status: not yet recruiting.

02

Drugs

sulfur hexafluoride
03

Conditions

Portal Hypertension (PH)Liver cirrhosis (LC)

Beyond the preview

Go deeper on NCT07365709.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07365709.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call